Not seeing what you're looking for?
TATAA carries thousands of products from our huge list of distributors.
Continue Shopping
Vendor: TATAA Biocenter AB
Fast and easy 1-tube cell lysis and reverse transcription of 1-500 cells The CelluLyser™ Micro lysis buffer has been de novo designed to provide improved mRNA retrieval even for very low expressed genes, enhanced stabilization of mRNA, minimal degree of dilution and high compatibility with downstream reagents.
By generating cDNA directly from cell lysate without any washing steps higher yields are achieved, and to avoid losses of material the entire procedure can be performed in a single tube (or 96/384-well plates) without any sample transfer.
The CelluLyser™ Micro lysis reagent has been developed for fast and simple cDNA preparation for single cell applications including very small samples (FACS sorted single cells, cell cultures, dissociated tissue).
Description The CelluLyser™ Micro's properties make direct lysis and analysis of small cell numbers more accurate, flexible and feasible.
The CelluLyser™ Micro buffer and cDNA synthesis kit has been developed for fast and simple cDNA preparation for single cell applications including very small samples: FACS sorted single cells, cell cultures, dissociated tissue.
By generating cDNA directly from cell lysate without any washing steps, higher yields are achieved, no bias in transcriptome is introduced and considerable amount of time is saved compared to standard column based purification (Svec et al. 2013). To avoid losses of material the entire procedure can be performed in a single tube (or 96/384-well plates) without any sample transfer, just adding reagents.
The whole process can be easily automated for high-throughput applications.
Features
Cell types The CelluLyser™ Micro buffer has been developed to be a mild lysis solution. It has been verified on many types of in vitro and in vivo viable cells including astrocytes, microglia, fibroblasts, lymphocytes (B-cells, T-cells), leukemia cell lines (K562, HEK293), monocytes, breast cancer cells, sarcoma cell lines and embryonic stem cells.
Contents